Technical Analysis for LJPC - La Jolla Pharmaceutical Company

Grade Last Price % Change Price Change
grade F 3.93 5.93% 0.22
LJPC closed up 5.93 percent on Friday, August 14, 2020, on approximately normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up
Historical LJPC trend table...

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 0.00%
Bullish Engulfing Bullish 5.93%
Wide Bands Range Expansion 5.93%
Oversold Stochastic Weakness 5.93%
Wide Bands Range Expansion 11.02%
Oversold Stochastic Weakness 11.02%
Lower Bollinger Band Walk Weakness 9.47%
Wide Bands Range Expansion 9.47%
Oversold Stochastic Weakness 9.47%
Doji - Bullish? Reversal 9.17%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for chronic organ failure and cancer. The company's products include GCS-100, a Phase-1/2 clinical trial drug used for the treatment of chronic kidney disease. It also provides LJPC-501, a peptide agonist of the renin-angiotensin system, which is designed to help restore kidney function in patients with hepatorenal syndrome. In addition, the company is developing LJPC-101, a subcutaneous formulation of GCS-100; LJPC-201, an oral galectin-3 inhibitor; and LJPC-301, a monoclonal antibody designed to neutralize galectin-3. La Jolla Pharmaceutical Company was founded in 1989 and is headquartered in San Diego, California.
Biopharmaceutical Cancer Life Sciences Pharmaceutical Industry Medication Chronic Kidney Disease Proteins Peptide Hormones Lectins Galectin Galectin 3 Hepatorenal Syndrome

Is LJPC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.41
52 Week Low 2.3
Average Volume 584,407
200-Day Moving Average 5.56
50-Day Moving Average 4.51
20-Day Moving Average 3.99
10-Day Moving Average 3.83
Average True Range 0.28
ADX 28.21
+DI 20.02
-DI 28.67
Chandelier Exit (Long, 3 ATRs ) 4.02
Chandelier Exit (Short, 3 ATRs ) 4.25
Upper Bollinger Band 4.57
Lower Bollinger Band 3.41
Percent B (%b) 0.45
BandWidth 29.12
MACD Line -0.24
MACD Signal Line -0.25
MACD Histogram 0.0113
Fundamentals Value
Market Cap 86.94 Million
Num Shares 22.1 Million
EPS -5.12
Price-to-Earnings (P/E) Ratio -0.77
Price-to-Sales 5475.91
Price-to-Book 5.28
PEG Ratio -0.48
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.35
Resistance 3 (R3) 4.31 4.14 4.28
Resistance 2 (R2) 4.14 4.03 4.16 4.26
Resistance 1 (R1) 4.03 3.96 4.09 4.07 4.23
Pivot Point 3.86 3.86 3.88 3.88 3.86
Support 1 (S1) 3.75 3.75 3.81 3.79 3.63
Support 2 (S2) 3.58 3.68 3.60 3.60
Support 3 (S3) 3.47 3.58 3.58
Support 4 (S4) 3.51